[go: up one dir, main page]

DK1082109T3 - Oral formulering omfattende biguanid og en organisk syre - Google Patents

Oral formulering omfattende biguanid og en organisk syre

Info

Publication number
DK1082109T3
DK1082109T3 DK99917144T DK99917144T DK1082109T3 DK 1082109 T3 DK1082109 T3 DK 1082109T3 DK 99917144 T DK99917144 T DK 99917144T DK 99917144 T DK99917144 T DK 99917144T DK 1082109 T3 DK1082109 T3 DK 1082109T3
Authority
DK
Denmark
Prior art keywords
biguanide
organic acid
oral formulation
saltiness
bitterness
Prior art date
Application number
DK99917144T
Other languages
English (en)
Inventor
Hiroyuki Nishii
Hirohisa Kobayashi
Kazuya Otoda
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Application granted granted Critical
Publication of DK1082109T3 publication Critical patent/DK1082109T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99917144T 1998-04-29 1999-04-26 Oral formulering omfattende biguanid og en organisk syre DK1082109T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13612698 1998-04-29

Publications (1)

Publication Number Publication Date
DK1082109T3 true DK1082109T3 (da) 2004-08-09

Family

ID=15167924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99917144T DK1082109T3 (da) 1998-04-29 1999-04-26 Oral formulering omfattende biguanid og en organisk syre

Country Status (11)

Country Link
US (1) US6517870B1 (da)
EP (1) EP1082109B1 (da)
JP (1) JP5255604B2 (da)
AT (1) ATE269069T1 (da)
AU (1) AU3536299A (da)
CA (1) CA2330485C (da)
DE (1) DE69918105T2 (da)
DK (1) DK1082109T3 (da)
ES (1) ES2224634T3 (da)
PT (1) PT1082109E (da)
WO (1) WO1999055320A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK2102003A3 (en) * 2000-08-07 2003-08-05 Ranbaxy Signature Llc Liquid formulation of metformin
JP4706096B2 (ja) * 2000-10-23 2011-06-22 大正製薬株式会社 不快な味を呈する塩基性薬物配合製剤
FR2818908B1 (fr) * 2000-12-29 2004-04-02 Dospharma Utilisation en tant que medicament d'un compose restituant in vivo des principes actifs
FR2818906B1 (fr) * 2000-12-29 2004-04-02 Dospharma Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
US6955806B2 (en) 2001-01-18 2005-10-18 Genzyme Corporation Ionene polymers and their use as antimicrobial agents
US7220312B2 (en) * 2002-03-13 2007-05-22 Micron Technology, Inc. Methods for treating semiconductor substrates
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20070053939A1 (en) * 2003-10-17 2007-03-08 Hideakira Yokoyama Biguanide drug-containing jelly preparation
WO2005055989A1 (ja) * 2003-12-09 2005-06-23 Dainippon Sumitomo Pharma Co., Ltd. 薬物含有粒子および該粒子を含む固形製剤
DE10360924A1 (de) * 2003-12-23 2005-07-28 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Metformin-haltige pharmazeutische Zusammensetzung
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102005006539A1 (de) * 2005-02-11 2006-08-24 Merck Patent Gmbh Biguanid enthaltende Zusammensetzungen
UY29445A1 (es) * 2005-03-30 2006-10-02 Generex Pharm Inc Composiciones para la transmisión transmucosa oral de la metformina
KR20080007371A (ko) * 2005-04-26 2008-01-18 다이닛본 스미토모 세이야꾸 가부시끼가이샤 비구아니드 화합물 함유 과립성 제제
WO2007055887A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
US20080188457A1 (en) * 2007-02-02 2008-08-07 Braincells, Inc. Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
KR20100020449A (ko) * 2007-07-23 2010-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 기호적으로 허용될 수 있는 인돌 세로토닌 수용체 작용제 경구 투여 제제 및 이를 사용하는 방법
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2011154975A2 (en) 2010-06-08 2011-12-15 Cadila Healthcare Limited Pharmaceutical compositions of metformin
WO2013055609A1 (en) 2011-10-12 2013-04-18 Merck Sharp & Dohme Corp. Pharmaceutical compositions that inhibit disproportionation
US8765811B2 (en) 2012-07-10 2014-07-01 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US9382187B2 (en) 2012-07-10 2016-07-05 Thetis Pharmaceuticals Llc Tri-salt form of metformin
US9505709B2 (en) 2014-05-05 2016-11-29 Thetis Pharmaceuticals Llc Compositions and methods relating to ionic salts of peptides
US9242008B2 (en) 2014-06-18 2016-01-26 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of fatty acids
EP3157936B1 (en) 2014-06-18 2018-10-17 Thetis Pharmaceuticals LLC Mineral amino-acid complexes of active agents
WO2017210604A1 (en) 2016-06-03 2017-12-07 Thetis Pharmaceuticals Llc Compositions and methods relating to salts of specialized pro-resolving mediators of inflammation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB539076A (en) 1940-03-18 1941-08-27 Mergenthaler Setzmaschfab Gmbh Improvements in or relating to typographical composing machines
DE2124256A1 (en) * 1971-05-15 1972-11-30 Dr Christian Brunnengraber Chemi sehe Fabrik & Co mbH 2400 Lübeck Oral antidiabetics - contg dicarboxylic amino acids
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
US4089957A (en) 1976-06-11 1978-05-16 Ab Kabi Therapeutic compositions against recurrent thrombosis
US5324748A (en) 1981-07-14 1994-06-28 Efamol Limited Method for enhancement of 1-series PG production
JPS60246325A (ja) 1984-05-18 1985-12-06 Takeda Chem Ind Ltd 苦味が軽減された苦味成分含有水性溶液
FR2611500B1 (fr) * 1987-03-06 1990-05-04 Lipha Emploi de derives du biguanide dans la preparation de medicaments
JP2643260B2 (ja) 1988-03-22 1997-08-20 藤沢薬品工業株式会社 シロップ剤
US4975465A (en) 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5260275A (en) 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
US5411755A (en) * 1993-02-16 1995-05-02 The Procter & Gamble Company Process and composition for sweet juice from cucurbitaceae fruit
JP2705787B2 (ja) 1994-09-30 1998-01-28 山之内製薬株式会社 苦味改善易服用性ｈ▲２▼ブロッカー固形製剤
JP3294033B2 (ja) * 1994-12-24 2002-06-17 俊博 森田 オブラート
JPH104939A (ja) * 1996-06-27 1998-01-13 Nippon Shinyaku Co Ltd 飲 料
JPH1036252A (ja) 1996-07-22 1998-02-10 Taisho Pharmaceut Co Ltd ベラドンナ（総）アルカロイド配合内服液剤
JP3658878B2 (ja) * 1996-08-05 2005-06-08 大正製薬株式会社 内服液剤
US6399658B1 (en) * 1996-12-24 2002-06-04 Sumitomo Pharmaceuticals Co., Ltd. Composition containing ascorbic acid
WO1999029314A1 (en) * 1997-12-08 1999-06-17 Bristol-Myers Squibb Company Novel salts of metformin and method

Also Published As

Publication number Publication date
EP1082109A1 (en) 2001-03-14
JP2010195839A (ja) 2010-09-09
EP1082109B1 (en) 2004-06-16
ATE269069T1 (de) 2004-07-15
PT1082109E (pt) 2004-10-29
AU3536299A (en) 1999-11-16
WO1999055320A1 (en) 1999-11-04
JP5255604B2 (ja) 2013-08-07
US6517870B1 (en) 2003-02-11
DE69918105D1 (de) 2004-07-22
CA2330485C (en) 2008-07-08
DE69918105T2 (de) 2005-07-07
ES2224634T3 (es) 2005-03-01
CA2330485A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
DK1082109T3 (da) Oral formulering omfattende biguanid og en organisk syre
DK1175149T3 (da) Desinficerende sammensætning baseret på H2O2, syrer og metaliioner
DK0943331T3 (da) Formuleringer indeholdende oxaliplatin
BR0307924A (pt) N-aril-2-oxazolidinona-5-carboxamidas e seus derivados
NO20031407D0 (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
FR2700473B1 (fr) Embout respiratoire intra-buccal anatomique.
DE59707620D1 (de) Elektrolyt-angereicherte Keimlinge enthaltendes Kombinationspräparat
DK1130968T3 (da) Pesticid sammensætning til frøbehandling
CY1111013T1 (el) Μεθοδος για τον περιορισμο καρπων
EP0657942A3 (en) Lateral bipolar transistor.
KR970002468A (ko) 화학증폭형 포지티브 레지스트 조성물
DE69428407D1 (de) Rauscharmer bipolarer Transistor
KR960012693A (ko) 베이스 접지 트랜지스터 증폭기
DE69905250D1 (de) Geschmacksverstärker
GB0007760D0 (en) Composition
TR199901017A3 (tr) Böcek ilaci terkibi.
ATE437578T1 (de) Riechstoff- und geschmackstoffzusammensetzungen
EP0616800A3 (en) Rieck fabric agent with extended diffusion.
DK1164845T3 (da) Landbrugskemisk sammensætning
TR199700147A2 (tr) Mikrop öldürücü terkip.
TR199901165A3 (tr) Piretroid bilesimi ve salgin hastaliklari için bunu içeren bilesikler.
IT1307264B1 (it) Composizioni insetticide.
TR199700155A2 (tr) Mikrop öldürücü terkip.
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
DE69926019D1 (de) G.723.1 audiokodierer